Navigation Links


NeuroVax at Biology News

NeuroVax at Biology Products
NeuroVax at Biology Technology
NeuroVax at Medicine News
NeuroVax at Medicine Products
NeuroVax at Medicine Technology

Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis

- New Data from Open-Label Study Presented at Federation ofClinical Immunology Societies (FOCIS) Annual Meeting - CARLSBAD, Calif., June 11, 2007 /PRNewswire-FirstCall/ --Orchestra Therapeutics, Inc. (Bulletin Board: OCHT) announced todaypositive new data from its completed Phase II open-label study ofNeuroVax(TM), an investigational T Cell Receptor (TCR) peptidevaccine for the treatment...
Other Tags
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
(Date:9/7/2008)...es to govern commercial and research activities in...to reflect new environmental realities and to temp...stems, according to several of the experts conveni...ng the International Polar Year. , Due to climat...is fast disappearing, creating new opportunities f...
(Date:9/5/2008)... will convene September 7-9 at the Stockholm City ...informatics field combines neuroscience and inform...aches to understanding the structure and function ...in disorders and diseases. With a broad internatio...rts from all disciplines contributing to neuroinfo...
(Date:9/5/2008)...ted computer model pioneered at Princeton Universi...y governments worldwide are recommending the wrong...bility of many drugs and therapies to treat malari...ng what is known as a single first-line therapy --...ents. Writing in the Sept. 16 issue of the Procee...
(Date:9/5/2008)...ies of a critically endangered vulture, whose numb...s to a few thousand, are too small to protect the ...analysis shows. , Adding wild birds to the capti...cial, but political and logistical barriers are ha... , The study was published online August 15 in t...
Breaking Biology News(10 mins):Experts meet on need for new rules to govern world's fragile polar regions 2Experts meet on need for new rules to govern world's fragile polar regions 3Experts meet on need for new rules to govern world's fragile polar regions 4Experts meet on need for new rules to govern world's fragile polar regions 5Experts meet on need for new rules to govern world's fragile polar regions 6INCF organizes the first congress dedicated to the emerging field of neuroinformatics 2Best way to treat malaria: Avoid using same drug for everyone, scientists say 2Best way to treat malaria: Avoid using same drug for everyone, scientists say 3Recovery efforts not enough for critically endangered Asian vulture 2Recovery efforts not enough for critically endangered Asian vulture 3Thoratecs ITC Division Receives FDA Warning Letter 5808 1Thoratecs ITC Division Receives FDA Warning Letter 5808 2Thoratecs ITC Division Receives FDA Warning Letter 5808 3Vapotherm Earns Achievement Award from U S Department Of Commerce 5804 1Vapotherm Earns Achievement Award from U S Department Of Commerce 5804 2Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 1Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 2Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 3Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 4Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 5Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 6Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 7Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 8Kiwa Bio Tech Third Quarter Revenues Increase 226 25 Nine Month Revenues 246 2 Million 1732 9New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 1New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 2New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 3New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 4New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 5New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 6New Anti TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 800 7
Other Contentspotatopotatopotatopotatopotatopresbyopiaprecociouseclampsiaeclampsiasoressoressorescomplicationscomplicationscomplicationscomplicationscomplicationscomplicationscomplicationscomplicationspreventionpreventionpreventionpreventionpreventionpreventionprevention